Kintor Pharmaceutical Ltd (HK:9939) has released an update.
Kintor Pharmaceutical Limited has announced an update on its board of directors and the composition of its three board committees. The update includes a list of executive, non-executive, and independent non-executive directors, along with their respective roles in the audit, remuneration, and nomination committees. The announcement aims to provide transparency to shareholders and the market regarding the company’s governance structure.
For further insights into HK:9939 stock, check out TipRanks’ Stock Analysis page.
